NEW YORK, June 1, 2012 /PRNewswire/ -- Faruqi & Faruqi,
LLP, a leading national securities law firm, is investigating
potential securities fraud at Tibet Pharmaceuticals, Inc. ("Tibet
Pharmaceuticals" or the "Company") (OTC: TBET).
(Logo:
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )
The investigation focuses on whether the Company and its
executives violated federal securities laws by failing to disclose
that Tibet Pharmaceuticals misrepresented and failed to disclose
material internal control deficiencies, which rendered the
Company's registration statement and prospectus to be materially
false and misleading. These problems ultimately caused NASDAQ to
halt and delist the Company's stock.
Request more information now by clicking here:
www.faruqilaw.com/TBET
Take Action
If you purchased Tibet Pharmaceutical securities after
December 28, 2010 and would like to
discuss your legal rights, visit www.faruqilaw.com/TBET. You
can also contact us by calling Juan
Monteverde, Richard Gonnello
or Francis McConville toll free at
877-247-4292 or at 212-983-9330 or by sending an e-mail to
jmonteverde@faruqilaw.com, rgonnello@faruqilaw.com or
fmcconville@faruqilaw.com. Faruqi & Faruqi, LLP also
encourages anyone with information regarding Tibet Pharmaceutical's
conduct to contact the firm, including whistleblowers, former
employees, shareholders and others.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or
predict a similar outcome with respect to any future matter.
We welcome the opportunity to discuss your particular case.
All communications will be treated in a confidential matter.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Juan E. Monteverde,
Esq.
jmonteverde@faruqilaw.com
Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Francis McConville, Esq.
fmcconville@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
SOURCE Faruqi & Faruqi, LLP